CVRx, Inc.

Contributing Author

Recent Articles by CVRx, Inc.

Jan-22	CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population CVRX GlobeNewswire
Jan-12	CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance CVRX GlobeNewswire
Jan-06	CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy CVRX GlobeNewswire
Dec-22	CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference CVRX GlobeNewswire
Nov-19	CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference CVRX GlobeNewswire
Nov-05	CVRx Reports Third Quarter 2025 Financial and Operating Results CVRX GlobeNewswire
Nov-04	CVRx to Present at the Jefferies Global Healthcare Conference in London CVRX GlobeNewswire
Oct-22	CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025 CVRX GlobeNewswire
Aug-04	CVRx Reports Second Quarter 2025 Financial and Operating Results CVRX GlobeNewswire
Jul-29	CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference CVRX GlobeNewswire
Jul-21	CVRx to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call on August 4, 2025 CVRX GlobeNewswire
Jul-16	CVRx Announces Positive News on Outpatient Payment for Barostim CVRX GlobeNewswire
May-28	CVRx to Present at the William Blair 45th Annual Growth Stock Conference CVRX GlobeNewswire
May-08	CVRx Reports First Quarter 2025 Financial and Operating Results CVRX GlobeNewswire